Aripiprazole

Aripiprazole is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions) in adults and teenagers 13 years of age and older. It is also used alone or with other medications to treat episodes of mania or mixed episodes (symptoms of mania and depression that happen together) in adults, teenagers, and children 10 years of age and older with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Aripiprazole is also used with an antidepressant to treat depression when symptoms cannot be controlled by the antidepressant alone. Aripiprazole is also used to treat children 6 to 17 years of age who have autistic disorder (a developmental problem that causes difficulty communicating and interacting with others). Aripiprazole may help control irritable behavior such as aggression, temper tantrums, and frequent mood changes in these children. Aripiprazole is also used to treat children 6 to 18 years of age who have Tourette's disorder (a condition characterized by the need to perform repeated motions or to repeat sounds or words). Aripiprazole is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.

Aripiprazole comes as a tablet, a solution (liquid), an orally disintegrating tablet (tablet that dissolves quickly in the mouth) to take by mouth. It is usually taken once a day with or without food. Apriprazole also comes as a tablet that contains a sensor device to take by mouth to be used in adults to provide information about how the medication is taken. Take aripiprazole at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take aripiprazole exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Do not try to push the orally disintegrating tablet through the foil. Instead, use dry hands to peel back the foil packaging. Immediately take out the tablet and place the entire tablet on your tongue. Do not try to split the tablet. The tablet will quickly dissolve and can be swallowed without liquid. If necessary, liquid can be used to take the orally disintegrating tablet.

Swallow the tablets and the tablet with a sensor whole; do not divide, crush, or chew.

The tablets that contain a small sensor come with a patch (a wearable sensor) that detects a signal from the tablet and a smartphone application (app) to display information about how you are taking the medication. The app must be downloaded onto your smartphone before you start the medication. Apply your patch to the left side of the body above the lower edge of the rib cage only when prompted by the smartphone app instructions. Do not place the patch in areas where the skin is scraped, cracked, inflamed, or irritated or in a location that overlaps the area of the most recently removed patch. Change the patch weekly or sooner, if needed. The app reminds you to change the patch and explains how to apply and remove the patch correctly. Keep the patch on when showering, swimming, or exercising. If undergoing a magnetic resonance imaging (MRI; a medical test that uses powerful magnets to take pictures of the inside of the body), remove the patch and replace it with a new one as soon as possible. If the patch causes skin irritation, remove it and tell your doctor. After you take the medication, the tablets can be detected in the body by the app within 30 minutes to 2 hours. If the tablet is not detected after ingestion, do not take another dose. Talk to your doctor if you have any questions about how to take the tablets and use the patch or smartphone app.

Your doctor may start you on a low dose of aripiprazole and gradually increase or decrease your dose depending on how well the medication works for you and the side effects you experience.

Aripiprazole may help control your symptoms but will not cure your condition. It may take 2 weeks or longer before you feel the full benefit of aripiprazole. Continue to take aripiprazole even if you feel well. Do not stop taking aripiprazole without talking to your doctor.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking aripiprazole,

• tell your doctor and pharmacist if you are allergic to aripiprazole, any other medications, or any of the ingredients in aripiprazole preparations. Ask your doctor or pharmacist or check the Medication Guide for a list of the ingredients.

• tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: antidepressants (mood elevators); antifungals such as itraconazole (Onmel, Sporanox) and ketoconazole; antihistamines; bupropion (Wellbutrin); clarithromycin (Biaxin); fluoxetine (Prozac, Sarafem); HIV protease inhibitors such as atazanavir (Reyataz), efavirenz (Sustiva), indinavir (Crixivan), nelfinavir (Viracept), nevirapine (Viramune), ritonavir (Norvir), and saquinavir (Invirase); ipratropium (Atrovent); medications for anxiety, high blood pressure, irritable bowel syndrome, mental illness, motion sickness, Parkinson's disease, ulcers, or urinary problems; lorazapam (Ativan); nefazodone; paroxetine (Paxil, Pexeva); pioglitazone (Actos, in Oseni); quinidine (in Nuedexta); rifabutin (Mycobutin); rifampin (Rifadin, Rimactane); sedatives; certain medications for seizures such as carbamazepine (Carbatrol, Epitol, Tegretol, others), phenobarbital, and phenytoin (Dilantin, Phenytek); sleeping pills; telithromycin (Ketek; no longer available in U.S.); and tranquilizers. Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with aripiprazole, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

• tell your doctor what herbal products you are taking, especially St. John's wort.

• tell your doctor if you have severe diarrhea or vomiting or you think you may be dehydrated. . Also tell your doctor if you have or have ever had heart disease, heart failure, a heart attack, an irregular heartbeat, high or low blood pressure, a stroke, a ministroke, seizures, a low number of white blood cells, dyslipidemia (high cholesterol levels), trouble keeping your balance, or any condition that makes it difficult for you to swallow. Tell your doctor if you or anyone in your family use or have ever used street drugs or have overused prescription medication or alcohol or has or has ever had diabetes, obsessive compulsive disorder, impulse-control disorder, bipolar disorder, or an impulsive personality. Also tell your doctor if you have ever had to stop taking a medication for mental illness because of severe side effects.

• tell your doctor if you are pregnant, especially if you are in the last few months of your pregnancy, or if you plan to become pregnant or are breastfeeding. If you become pregnant while taking aripiprazole, call your doctor. Aripiprazole may cause problems in newborns following delivery if it is taken during the last months of pregnancy.

• if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking aripiprazole.

• you should know that aripiprazole may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.

• you should know that alcohol can add to the drowsiness caused by this medication. Do not drink alcohol while taking aripiprazole.

• you should know that you may experience hyperglycemia (increases in your blood sugar) while you are taking this medication, even if you do not already have diabetes. If you have schizophrenia, you are more likely to develop diabetes than people who do not have schizophrenia, and taking aripiprazole or similar medications may increase this risk. Tell your doctor immediately if you have any of the following symptoms while you are taking aripiprazole: extreme thirst, frequent urination, extreme hunger, blurred vision, or weakness. It is very important to call your doctor as soon as you have any of these symptoms, because high blood sugar that is not treated can cause a serious condition called ketoacidosis. Ketoacidosis may become life-threatening if it is not treated at an early stage. Symptoms of ketoacidosis include dry mouth, nausea and vomiting, shortness of breath, breath that smells fruity, and decreased consciousness.

• you should know that aripiprazole may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position. This is more common when you first start taking aripiprazole. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.

• you should know that aripiprazole may make it harder for your body to cool down when it gets very hot. Tell your doctor if you plan to do vigorous exercise or be exposed to extreme heat.

• if you have phenylketonuria (PKU, an inherited condition in which a special diet must be followed to prevent damage to your brain that can cause severe intellectual disability), you should know that the orally disintegrating tablets contain phenylalanine. If you have diabetes, you should know that aripiprazole solution contains sugar.

• you should know that some people who took medications such as aripiprazole developed gambling problems or other intense urges or behaviors that were compulsive or unusual for them, such as increased sexual urges or behaviors, excessive shopping, and binge eating. Call your doctor if you have intense urges to shop, eat, have sex, or gamble, or you are unable to control your behavior. Tell your family members about this risk so that they can call the doctor even if you do not realize that your gambling or any other intense urges or unusual behaviors such as have become a problem.

• you should know that when aripiprazole is used to treat children, it should be used as part of a treatment program that may include counseling and special education. Be sure that your child follows all of his or her doctor's or therapist's instructions.

Talk to your doctor about drinking grapefruit juice while taking this medicine.

Be sure to drink plenty of water every day while you are taking this medication.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

• Aripiprazole may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • headache

  • nervousness

  • restlessness

  • dizziness, feeling unsteady, or having trouble keeping your balance

  • heartburn

  • constipation

  • diarrhea

  • stomach pain

  • weight gain

  • changes in appetite

  • increased salivation

  • pain, especially in the arms, legs, or joints

  • tiredness

• Some side effects can be serious. If you experience any of the following symptoms or those listed in the IMPORTANT WARNING section or the SPECIAL PRECAUTIONS section, call your doctor immediately:

  • rash

  • hives

  • itching

  • swelling of the eyes, face, mouth, lips, tongue, throat, hands, feet, ankles, or lower legs

  • difficulty breathing or swallowing

  • seizures

  • changes in vision

  • uncontrollable shaking of the face, tongue, or other body parts

  • fever; stiff muscles; sweating; confusion; sweating; or fast, pounding, or irregular heartbeat

  • problems with coordination or increased falls

  • tightening of the neck muscles

  • throat tightness

• Aripiprazole may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

• If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store the tablets, the solution, and the orally disintegrating tablets at room temperature and away from excess heat and moisture (not in the bathroom). Store the orally disintegrating tablets in their sealed package, and use them immediately after opening the package. Store the tablets with a sensor at room temperature; do not store in places with high humidity. Dispose of any unused aripiprazole solution 6 months after you open the bottle or when the expiration date marked on the bottle has passed, whichever is sooner.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

• drowsiness

• weakness

• widened pupils (black circles in the middle of the eyes)

• nausea

• vomiting

• changes in heartbeat

• movements that you cannot control

• confusion

• seizures

• loss of consciousness

Keep all appointments with your doctor and the laboratory. Your doctor may order laboratory tests before and during your treatment with aripiprazole.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug	Interaction
Moxifloxacin	Moxifloxacin The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Moxifloxacin.
Repaglinide	Repaglinide The therapeutic efficacy of Repaglinide can be decreased when used in combination with Aripiprazole.
Insulin Glargine (rDNA origin) Injection	Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Aripiprazole.
Delavirdine	Delavirdine The metabolism of Aripiprazole can be decreased when combined with Delavirdine.
Nevirapine	Nevirapine The metabolism of Aripiprazole can be decreased when combined with Nevirapine.
Atorvastatin	Atorvastatin The metabolism of Aripiprazole can be decreased when combined with Atorvastatin.
Dolasetron	Dolasetron The risk or severity of adverse effects can be increased when Dolasetron is combined with Aripiprazole.
Anagrelide	Anagrelide The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Anagrelide.
Bisacodyl	Bisacodyl The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Aripiprazole.
Candesartan	Candesartan The risk or severity of hypotension can be increased when Aripiprazole is combined with Candesartan.
Cilostazol	Cilostazol The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Aripiprazole.
Clopidogrel	Clopidogrel The metabolism of Aripiprazole can be decreased when combined with Clopidogrel.
Diphenoxylate	Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Aripiprazole.
Erythromycin and Sulfisoxazole	Erythromycin and Sulfisoxazole The metabolism of Aripiprazole can be decreased when combined with Erythromycin.
Guanfacine	Guanfacine The risk or severity of hypotension can be increased when Aripiprazole is combined with Guanfacine.
Magnesium Hydroxide	Magnesium Hydroxide The therapeutic efficacy of Magnesium hydroxide can be decreased when used in combination with Aripiprazole.
Magnesium Oxide	Magnesium Oxide The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Aripiprazole.
Methylergonovine	Methylergonovine The metabolism of Aripiprazole can be decreased when combined with Methylergometrine.
Miglitol	Miglitol The therapeutic efficacy of Miglitol can be decreased when used in combination with Aripiprazole.
Naratriptan	Naratriptan The risk or severity of adverse effects can be increased when Naratriptan is combined with Aripiprazole.
Olsalazine	Olsalazine The risk or severity of hypertension can be increased when Aripiprazole is combined with Olsalazine.
Paregoric	Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Aripiprazole.
Penbutolol	Penbutolol The risk or severity of hypotension can be increased when Aripiprazole is combined with Acebutolol.
Pentazocine	Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Aripiprazole.
Polyethylene glycol-electrolyte solution (PEG-ES)	Polyethylene glycol-electrolyte solution (PEG-ES) The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Aripiprazole.
Psyllium	Psyllium The therapeutic efficacy of Plantago seed can be decreased when used in combination with Aripiprazole.
Ranitidine	Ranitidine The metabolism of Aripiprazole can be decreased when combined with Ranitidine.
Reserpine	Reserpine The risk or severity of hypotension can be increased when Aripiprazole is combined with Reserpine.
Rizatriptan	Rizatriptan The risk or severity of adverse effects can be increased when Rizatriptan is combined with Aripiprazole.
Sumatriptan	Sumatriptan The risk or severity of adverse effects can be increased when Sumatriptan is combined with Aripiprazole.
Tacrolimus	Tacrolimus The metabolism of Aripiprazole can be decreased when combined with Tacrolimus.
Tizanidine	Tizanidine The risk or severity of adverse effects can be increased when Tizanidine is combined with Aripiprazole.
Triamcinolone	Triamcinolone The metabolism of Aripiprazole can be increased when combined with Triamcinolone.
Zolmitriptan	Zolmitriptan The risk or severity of vasospastic reactions can be increased when Zolmitriptan is combined with Aripiprazole.
Famotidine Injection	Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Aripiprazole.
Fluconazole Injection	Fluconazole Injection The metabolism of Aripiprazole can be decreased when combined with Fluconazole.
Foscarnet Injection	Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Aripiprazole.
Hydromorphone Injection	Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Aripiprazole.
Levofloxacin Injection	Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Levofloxacin.
Meperidine Injection	Meperidine Injection The metabolism of Aripiprazole can be increased when combined with Meperidine.
Methylprednisolone Injection	Methylprednisolone Injection The metabolism of Aripiprazole can be increased when combined with Methylprednisolone.
Metoclopramide Injection	Metoclopramide Injection The risk or severity of adverse effects can be increased when Metoclopramide is combined with Aripiprazole.
Metronidazole Injection	Metronidazole Injection The metabolism of Aripiprazole can be decreased when combined with Metronidazole.
Morphine Injection	Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Aripiprazole.
Altretamine	Altretamine Amphetamine may decrease the sedative and stimulatory activities of Aripiprazole.
Cyclosporine	Cyclosporine The metabolism of Aripiprazole can be decreased when combined with Cyclosporine.
Ondansetron	Ondansetron The risk or severity of adverse effects can be increased when Ondansetron is combined with Aripiprazole.
Granisetron	Granisetron The risk or severity of adverse effects can be increased when Granisetron is combined with Aripiprazole.
Torsemide	Torsemide The risk or severity of hypotension can be increased when Aripiprazole is combined with Torasemide.
Olanzapine	Olanzapine Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Alosetron	Alosetron The risk or severity of adverse effects can be increased when Alosetron is combined with Aripiprazole.
Dofetilide	Dofetilide The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Dofetilide.
Entacapone	Entacapone The therapeutic efficacy of Entacapone can be decreased when used in combination with Aripiprazole.
Eprosartan	Eprosartan The risk or severity of hypotension can be increased when Aripiprazole is combined with Eprosartan.
Hydroxychloroquine	Hydroxychloroquine The metabolism of Aripiprazole can be decreased when combined with Hydroxychloroquine.
Meloxicam	Meloxicam The risk or severity of hypertension can be increased when Meloxicam is combined with Aripiprazole.
Orlistat	Orlistat The metabolism of Aripiprazole can be increased when combined with Orlistat.
Oxcarbazepine	Oxcarbazepine The metabolism of Aripiprazole can be increased when combined with Oxcarbazepine.
Telmisartan	Telmisartan The risk or severity of hypotension can be increased when Aripiprazole is combined with Telmisartan.
Zaleplon	Zaleplon The risk or severity of adverse effects can be increased when Zaleplon is combined with Aripiprazole.
Anakinra	Anakinra The metabolism of Aripiprazole can be increased when combined with Anakinra.
Desloratadine	Desloratadine Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Desloratadine.
Linezolid	Linezolid The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Aripiprazole.
Rivastigmine	Rivastigmine The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Rivastigmine.
Trimipramine	Trimipramine Trimipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Etanercept Injection	Etanercept Injection The metabolism of Aripiprazole can be increased when combined with Etanercept.
Glycopyrrolate	Glycopyrrolate The risk or severity of adverse effects can be increased when Aripiprazole is combined with Glycopyrronium.
Modafinil	Modafinil The metabolism of Aripiprazole can be increased when combined with Modafinil.
Perindopril	Perindopril The risk or severity of hypotension can be increased when Aripiprazole is combined with Perindopril.
Choline Magnesium Trisalicylate	Choline Magnesium Trisalicylate The risk or severity of hypertension can be increased when Aripiprazole is combined with Choline magnesium trisalicylate.
Sirolimus	Sirolimus The metabolism of Sirolimus can be decreased when combined with Aripiprazole.
Dutasteride	Dutasteride The metabolism of Aripiprazole can be decreased when combined with Dutasteride.
Epinephrine Injection	Epinephrine Injection The metabolism of Aripiprazole can be decreased when combined with Epinephrine.
Eplerenone	Eplerenone The risk or severity of hypotension can be increased when Aripiprazole is combined with Eplerenone.
Escitalopram	Escitalopram The risk or severity of serotonin syndrome can be increased when Escitalopram is combined with Aripiprazole.
Olmesartan	Olmesartan The risk or severity of hypotension can be increased when Aripiprazole is combined with Olmesartan.
Zonisamide	Zonisamide The risk or severity of adverse effects can be increased when Zonisamide is combined with Aripiprazole.
Adalimumab Injection	Adalimumab Injection The metabolism of Aripiprazole can be increased when combined with Adalimumab.
Atomoxetine	Atomoxetine The risk or severity of adverse effects can be increased when Atomoxetine is combined with Aripiprazole.
Dexmethylphenidate	Dexmethylphenidate The risk or severity of adverse effects can be increased when Aripiprazole is combined with Dexmethylphenidate.
Atazanavir	Atazanavir The metabolism of Aripiprazole can be decreased when combined with Atazanavir.
Almotriptan	Almotriptan The risk or severity of adverse effects can be increased when Almotriptan is combined with Aripiprazole.
Eletriptan	Eletriptan Eletriptan may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.
Mefloquine	Mefloquine The metabolism of Aripiprazole can be decreased when combined with Mefloquine.
Polyethylene Glycol 3350	Polyethylene Glycol 3350 The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Aripiprazole.
Rosuvastatin	Rosuvastatin The metabolism of Aripiprazole can be decreased when combined with Rosuvastatin.
Vardenafil	Vardenafil The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Aripiprazole.
Alfuzosin	Alfuzosin Alfuzosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Aprepitant	Aprepitant The metabolism of Aripiprazole can be decreased when combined with Aprepitant.
Memantine	Memantine The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Memantine.
Tegaserod	Tegaserod The metabolism of Aripiprazole can be decreased when combined with Tegaserod.
Tadalafil	Tadalafil The risk or severity of hypotension can be increased when Aripiprazole is combined with Tadalafil.
Frovatriptan	Frovatriptan The risk or severity of adverse effects can be increased when Frovatriptan is combined with Aripiprazole.
Gemifloxacin	Gemifloxacin The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Gemifloxacin.
Progesterone	Progesterone The metabolism of Aripiprazole can be increased when combined with Progesterone.
Apomorphine Injection	Apomorphine Injection The risk or severity of adverse effects can be decreased when Apomorphine is combined with Aripiprazole.
Infliximab Injection	Infliximab Injection The metabolism of Aripiprazole can be increased when combined with Infliximab.
Protriptyline	Protriptyline Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.
Rifaximin	Rifaximin The metabolism of Aripiprazole can be increased when combined with Rifaximin.
Duloxetine	Duloxetine The metabolism of Aripiprazole can be decreased when combined with Duloxetine.
Norethindrone	Norethindrone The metabolism of Aripiprazole can be decreased when combined with Norethisterone.
Trospium	Trospium The metabolism of Aripiprazole can be decreased when combined with Trospium.
Bosentan	Bosentan The metabolism of Aripiprazole can be increased when combined with Bosentan.
Cinacalcet	Cinacalcet The metabolism of Aripiprazole can be decreased when combined with Cinacalcet.
Erlotinib	Erlotinib The metabolism of Aripiprazole can be decreased when combined with Erlotinib.
Eszopiclone	Eszopiclone The risk or severity of CNS depression can be increased when Aripiprazole is combined with Eszopiclone.
Insulin Aspart (rDNA Origin) Injection	Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Aripiprazole.
Solifenacin	Solifenacin Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Voriconazole	Voriconazole The metabolism of Aripiprazole can be decreased when combined with Voriconazole.
Dextroamphetamine	Dextroamphetamine Amphetamine may decrease the sedative and stimulatory activities of Aripiprazole.
Peginterferon Alfa-2b (PEG-Intron)	Peginterferon Alfa-2b (PEG-Intron) The metabolism of Aripiprazole can be decreased when combined with Peginterferon alfa-2b.
Pramlintide Injection	Pramlintide Injection The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Aripiprazole.
Sodium Oxybate	Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.
Exenatide Injection	Exenatide Injection The therapeutic efficacy of Exenatide can be decreased when used in combination with Aripiprazole.
Ibandronate	Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Aripiprazole.
Isocarboxazid	Isocarboxazid The risk or severity of serotonin syndrome can be increased when Aripiprazole is combined with Isocarboxazid.
Ramelteon	Ramelteon The risk or severity of adverse effects can be increased when Ramelteon is combined with Aripiprazole.
Darifenacin	Darifenacin The metabolism of Darifenacin can be decreased when combined with Aripiprazole.
Fentanyl	Fentanyl The risk or severity of adverse effects can be increased when Aripiprazole is combined with Fentanyl.
Pregabalin	Pregabalin The therapeutic efficacy of Aripiprazole can be increased when used in combination with Pregabalin.
Deferasirox	Deferasirox The metabolism of Aripiprazole can be increased when combined with Deferasirox.
Phenylephrine	Phenylephrine The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Aripiprazole.
Tipranavir	Tipranavir The metabolism of Aripiprazole can be decreased when combined with Tipranavir.
Felbamate	Felbamate The metabolism of Aripiprazole can be increased when combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection	Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Aripiprazole.
Ranolazine	Ranolazine The serum concentration of Aripiprazole can be increased when it is combined with Ranolazine.
Abatacept Injection	Abatacept Injection The metabolism of Aripiprazole can be increased when combined with Abatacept.
Rasagiline	Rasagiline The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Aripiprazole.
Imatinib	Imatinib The metabolism of Aripiprazole can be decreased when combined with Imatinib.
Sitagliptin	Sitagliptin The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Aripiprazole.
Gefitinib	Gefitinib The metabolism of Aripiprazole can be decreased when combined with Gefitinib.
Albuterol	Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Aripiprazole.
Paliperidone	Paliperidone Aripiprazole may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Paliperidone.
Bortezomib	Bortezomib The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Aripiprazole.
Clofarabine Injection	Clofarabine Injection Aripiprazole may increase the hypotensive activities of Clofarabine.
Insulin Glulisine (rDNA origin) Injection	Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Aripiprazole.
Lubiprostone	Lubiprostone The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Aripiprazole.
Oxaliplatin Injection	Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Oxaliplatin.
Posaconazole	Posaconazole The metabolism of Aripiprazole can be decreased when combined with Posaconazole.
Primaquine	Primaquine The metabolism of Aripiprazole can be decreased when combined with Primaquine.
Aliskiren	Aliskiren The risk or severity of hypotension can be increased when Aripiprazole is combined with Aliskiren.
Bismuth Subsalicylate	Bismuth Subsalicylate Aripiprazole may increase the neurotoxic activities of Bismuth subsalicylate.
Darunavir	Darunavir The metabolism of Aripiprazole can be decreased when combined with Darunavir.
Dimenhydrinate	Dimenhydrinate The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Aripiprazole.
Lisdexamfetamine	Lisdexamfetamine Lisdexamfetamine may decrease the sedative and stimulatory activities of Aripiprazole.
Nabilone	Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.
Vorinostat	Vorinostat The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Vorinostat.
Sorafenib	Sorafenib The metabolism of Aripiprazole can be decreased when combined with Sorafenib.
Sunitinib	Sunitinib The metabolism of Aripiprazole can be decreased when combined with Sunitinib.
Dronabinol	Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.
Lapatinib	Lapatinib The metabolism of Aripiprazole can be decreased when combined with Lapatinib.
Levocetirizine	Levocetirizine The risk or severity of adverse effects can be increased when Aripiprazole is combined with Levocetirizine.
Dasatinib	Dasatinib The metabolism of Aripiprazole can be decreased when combined with Dasatinib.
Mexiletine	Mexiletine The metabolism of Aripiprazole can be decreased when combined with Mexiletine.
Armodafinil	Armodafinil The metabolism of Aripiprazole can be increased when combined with Armodafinil.
Paclitaxel (with polyoxyethylated castor oil) Injection	Paclitaxel (with polyoxyethylated castor oil) Injection The therapeutic efficacy of Castor oil can be decreased when used in combination with Aripiprazole.
Temsirolimus	Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Aripiprazole.
Nilotinib	Nilotinib The metabolism of Aripiprazole can be decreased when combined with Nilotinib.
Toremifene	Toremifene The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Toremifene.
Bexarotene	Bexarotene The metabolism of Aripiprazole can be increased when combined with Bexarotene.
Budesonide	Budesonide The metabolism of Aripiprazole can be increased when combined with Budesonide.
Chloramphenicol Injection	Chloramphenicol Injection The metabolism of Aripiprazole can be decreased when combined with Chloramphenicol.
Desmopressin	Desmopressin The risk or severity of hypertension can be increased when Desmopressin is combined with Aripiprazole.
Betaine	Betaine The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Glycine betaine.
OnabotulinumtoxinA Injection	OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Aripiprazole is combined with Botulinum toxin type A.
RimabotulinumtoxinB Injection	RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Aripiprazole is combined with Botulinum Toxin Type B.
Etravirine	Etravirine The metabolism of Aripiprazole can be increased when combined with Etravirine.
Arsenic Trioxide Injection	Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Arsenic trioxide.
Mitoxantrone Injection	Mitoxantrone Injection The metabolism of Aripiprazole can be decreased when combined with Mitoxantrone.
Desvenlafaxine	Desvenlafaxine The metabolism of Aripiprazole can be decreased when combined with Desvenlafaxine.
Cevimeline	Cevimeline The metabolism of Aripiprazole can be decreased when combined with Cevimeline.
Nebivolol	Nebivolol The risk or severity of hypotension can be increased when Aripiprazole is combined with Nebivolol.
Tretinoin	Tretinoin The metabolism of Aripiprazole can be decreased when combined with Tretinoin.
Pilocarpine	Pilocarpine The metabolism of Aripiprazole can be decreased when combined with Pilocarpine.
Flecainide	Flecainide The metabolism of Flecainide can be decreased when combined with Aripiprazole.
Certolizumab Injection	Certolizumab Injection The metabolism of Aripiprazole can be increased when combined with Certolizumab pegol.
Irinotecan Injection	Irinotecan Injection The metabolism of Aripiprazole can be decreased when combined with Irinotecan.
Praziquantel	Praziquantel The metabolism of Aripiprazole can be decreased when combined with Praziquantel.
Mitotane	Mitotane The metabolism of Aripiprazole can be increased when combined with Mitotane.
Rufinamide	Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Aripiprazole.
Silodosin	Silodosin Aripiprazole may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Silodosin.
Midazolam	Midazolam The metabolism of Aripiprazole can be decreased when combined with Midazolam.
Naltrexone Injection	Naltrexone Injection The risk or severity of adverse effects can be increased when Naltrexone is combined with Aripiprazole.
Milnacipran	Milnacipran The metabolism of Aripiprazole can be decreased when combined with Milnacipran.
Sodium Phosphate	Sodium Phosphate The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Aripiprazole.
Fesoterodine	Fesoterodine Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Degarelix Injection	Degarelix Injection The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Degarelix.
Betaxolol	Betaxolol The risk or severity of hypotension can be increased when Aripiprazole is combined with Betaxolol.
Iloperidone	Iloperidone Aripiprazole may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.
Lacosamide	Lacosamide The risk or severity of adverse effects can be increased when Aripiprazole is combined with Lacosamide.
Everolimus	Everolimus The metabolism of Everolimus can be decreased when combined with Aripiprazole.
Dronedarone	Dronedarone The metabolism of Aripiprazole can be decreased when combined with Dronedarone.
AbobotulinumtoxinA Injection	AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Aripiprazole is combined with Botulinum toxin type A.
Palonosetron Injection	Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Aripiprazole.
Saxagliptin	Saxagliptin The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Aripiprazole.
Telavancin Injection	Telavancin Injection The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Telavancin.
Romidepsin Injection	Romidepsin Injection The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Romidepsin.
Tapentadol	Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.
Topotecan	Topotecan The metabolism of Aripiprazole can be increased when combined with Topotecan.
Golimumab Injection	Golimumab Injection The metabolism of Aripiprazole can be increased when combined with Golimumab.
Pazopanib	Pazopanib The metabolism of Aripiprazole can be decreased when combined with Pazopanib.
Asenapine	Asenapine Aripiprazole may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.
Vigabatrin	Vigabatrin The risk or severity of adverse effects can be increased when Vigabatrin is combined with Aripiprazole.
Levonorgestrel	Levonorgestrel The metabolism of Aripiprazole can be decreased when combined with Levonorgestrel.
Oxymorphone	Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Aripiprazole.
Liraglutide Injection	Liraglutide Injection The therapeutic efficacy of Liraglutide can be decreased when used in combination with Aripiprazole.
Tocilizumab Injection	Tocilizumab Injection The metabolism of Aripiprazole can be increased when combined with Tocilizumab.
Eribulin Injection	Eribulin Injection The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Eribulin.
IncobotulinumtoxinA Injection	IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Aripiprazole is combined with Botulinum toxin type A.
Cabazitaxel Injection	Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Aripiprazole.
Lurasidone	Lurasidone Aripiprazole may increase the hypotensive activities of Lurasidone.
Acetaminophen Injection	Acetaminophen Injection The metabolism of Aripiprazole can be increased when combined with Acetaminophen.
Vilazodone	Vilazodone The metabolism of Vilazodone can be decreased when combined with Aripiprazole.
Denileukin Diftitox Injection	Denileukin Diftitox Injection The metabolism of Aripiprazole can be decreased when combined with Aldesleukin.
Terbutaline Injection	Terbutaline Injection The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Terbutaline.
Azilsartan	Azilsartan Aripiprazole may increase the hypotensive activities of Azilsartan medoxomil.
Linagliptin	Linagliptin The metabolism of Aripiprazole can be decreased when combined with Linagliptin.
Rilpivirine	Rilpivirine The metabolism of Aripiprazole can be decreased when combined with Rilpivirine.
Cyclophosphamide Injection	Cyclophosphamide Injection The metabolism of Aripiprazole can be increased when combined with Cyclophosphamide.
Abiraterone	Abiraterone The metabolism of Aripiprazole can be decreased when combined with Abiraterone.
Triptorelin Injection	Triptorelin Injection The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Triptorelin.
Rivaroxaban	Rivaroxaban The metabolism of Rivaroxaban can be decreased when combined with Aripiprazole.
Ticagrelor	Ticagrelor The metabolism of Aripiprazole can be decreased when combined with Ticagrelor.
Brentuximab Vedotin Injection	Brentuximab Vedotin Injection The metabolism of Aripiprazole can be decreased when combined with Brentuximab vedotin.
Vandetanib	Vandetanib The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Vandetanib.
Clobazam	Clobazam The metabolism of Aripiprazole can be decreased when combined with Clobazam.
Vemurafenib	Vemurafenib The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Aripiprazole.
Ivacaftor	Ivacaftor The metabolism of Aripiprazole can be decreased when combined with Ivacaftor.
Axitinib	Axitinib The metabolism of Axitinib can be decreased when combined with Aripiprazole.
Crizotinib	Crizotinib The metabolism of Aripiprazole can be decreased when combined with Crizotinib.
Cabergoline	Cabergoline The metabolism of Aripiprazole can be decreased when combined with Cabergoline.
Naloxone Injection	Naloxone Injection The metabolism of Aripiprazole can be decreased when combined with Naloxone.
Ambrisentan	Ambrisentan The risk or severity of hypotension can be increased when Aripiprazole is combined with Ambrisentan.
Ezogabine	Ezogabine The risk or severity of adverse effects can be increased when Tiagabine is combined with Aripiprazole.
Iloprost	Iloprost Aripiprazole may increase the hypotensive activities of Iloprost.
Enzalutamide	Enzalutamide The metabolism of Aripiprazole can be increased when combined with Enzalutamide.
Mirabegron	Mirabegron The risk or severity of urinary retention can be increased when Aripiprazole is combined with Mirabegron.
Regorafenib	Regorafenib The metabolism of Aripiprazole can be decreased when combined with Regorafenib.
Bosutinib	Bosutinib The metabolism of Aripiprazole can be decreased when combined with Bosutinib.
Corticotropin, Repository Injection	Corticotropin, Repository Injection The metabolism of Aripiprazole can be increased when combined with Corticotropin.
Linaclotide	Linaclotide The therapeutic efficacy of Linaclotide can be decreased when used in combination with Aripiprazole.
Lorcaserin	Lorcaserin The therapeutic efficacy of Mecasermin can be decreased when used in combination with Aripiprazole.
Bedaquiline	Bedaquiline The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Bedaquiline.
Alogliptin	Alogliptin The therapeutic efficacy of Alogliptin can be decreased when used in combination with Aripiprazole.
Ponatinib	Ponatinib The metabolism of Ponatinib can be decreased when combined with Aripiprazole.
Pomalidomide	Pomalidomide The risk or severity of adverse effects can be increased when Aripiprazole is combined with Pomalidomide.
Ado-trastuzumab Emtansine Injection	Ado-trastuzumab Emtansine Injection The metabolism of Aripiprazole can be decreased when combined with Trastuzumab emtansine.
Apixaban	Apixaban The metabolism of Apixaban can be decreased when combined with Aripiprazole.
Canagliflozin	Canagliflozin The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Aripiprazole.
Methazolamide	Methazolamide Aripiprazole may increase the hypotensive activities of Methazolamide.
Dabrafenib	Dabrafenib The metabolism of Aripiprazole can be increased when combined with Dabrafenib.
Ospemifene	Ospemifene The metabolism of Aripiprazole can be decreased when combined with Ospemifene.
Trametinib	Trametinib The metabolism of Aripiprazole can be increased when combined with Trametinib.
Levomilnacipran	Levomilnacipran The risk or severity of adverse effects can be increased when Aripiprazole is combined with Levomilnacipran.
Vortioxetine	Vortioxetine The risk or severity of adverse effects can be increased when Aripiprazole is combined with Vortioxetine.
Perampanel	Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.
Ibrutinib	Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Aripiprazole.
Lomitapide	Lomitapide The metabolism of Aripiprazole can be decreased when combined with Lomitapide.
Avanafil	Avanafil The risk or severity of hypotension, dyspepsia, and headache can be increased when Avanafil is combined with Aripiprazole.
Ketorolac Injection	Ketorolac Injection The risk or severity of hypertension can be increased when Ketorolac is combined with Aripiprazole.
Obinutuzumab Injection	Obinutuzumab Injection Aripiprazole may increase the hypotensive activities of Obinutuzumab.
Simeprevir	Simeprevir The metabolism of Aripiprazole can be decreased when combined with Simeprevir.
Dapagliflozin	Dapagliflozin The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Aripiprazole.
Apremilast	Apremilast The metabolism of Aripiprazole can be increased when combined with Apremilast.
Droxidopa	Droxidopa Aripiprazole may increase the hypertensive activities of Droxidopa.
Ceritinib	Ceritinib The metabolism of Aripiprazole can be decreased when combined with Ceritinib.
Siltuximab Injection	Siltuximab Injection The metabolism of Aripiprazole can be increased when combined with Siltuximab.
Albiglutide Injection	Albiglutide Injection The therapeutic efficacy of Albiglutide can be decreased when used in combination with Aripiprazole.
Eslicarbazepine	Eslicarbazepine The metabolism of Aripiprazole can be increased when combined with Eslicarbazepine.
Idelalisib	Idelalisib The metabolism of Aripiprazole can be decreased when combined with Idelalisib.
Testosterone Injection	Testosterone Injection The metabolism of Aripiprazole can be increased when combined with Testosterone.
Oritavancin Injection	Oritavancin Injection The metabolism of Aripiprazole can be increased when combined with Oritavancin.
Empagliflozin	Empagliflozin The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Aripiprazole.
Hydrocodone	Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.
Suvorexant	Suvorexant Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Dulaglutide Injection	Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Aripiprazole.
Olaparib	Olaparib The metabolism of Aripiprazole can be decreased when combined with Olaparib.
Methamphetamine	Methamphetamine Metamfetamine may decrease the sedative and stimulatory activities of Aripiprazole.
Tasimelteon	Tasimelteon The risk or severity of adverse effects can be increased when Aripiprazole is combined with Tasimelteon.
Riociguat	Riociguat The risk or severity of hypotension can be increased when Aripiprazole is combined with Riociguat.
Lanreotide Injection	Lanreotide Injection The metabolism of Aripiprazole can be decreased when combined with Lanreotide.
Secukinumab Injection	Secukinumab Injection The metabolism of Aripiprazole can be increased when combined with Secukinumab.
Risperidone Injection	Risperidone Injection Risperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Palbociclib	Palbociclib The metabolism of Aripiprazole can be decreased when combined with Palbociclib.
Insulin Human Inhalation	Insulin Human Inhalation The therapeutic efficacy of Insulin human can be decreased when used in combination with Aripiprazole.
Lenvatinib	Lenvatinib The metabolism of Aripiprazole can be increased when combined with Lenvatinib.
Naloxegol	Naloxegol The metabolism of Naloxegol can be decreased when combined with Aripiprazole.
Panobinostat	Panobinostat The metabolism of Aripiprazole can be decreased when combined with Panobinostat.
Dinutuximab Injection	Dinutuximab Injection Aripiprazole may increase the hypotensive activities of Dinutuximab.
Haloperidol Injection	Haloperidol Injection The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Aripiprazole.
Ivabradine	Ivabradine The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Ivabradine.
Amiloride	Amiloride Aripiprazole may increase the hypotensive activities of Amiloride.
Isavuconazonium Injection	Isavuconazonium Injection The metabolism of Aripiprazole can be increased when combined with Isavuconazonium.
Macitentan	Macitentan The risk or severity of hypotension can be increased when Aripiprazole is combined with Macitentan.
Flibanserin	Flibanserin The risk or severity of adverse effects can be increased when Aripiprazole is combined with Flibanserin.
Rolapitant	Rolapitant The metabolism of Aripiprazole can be decreased when combined with Rolapitant.
Prednisolone	Prednisolone The metabolism of Aripiprazole can be increased when combined with Prednisolone.
Daclatasvir	Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Aripiprazole.
Brexpiprazole	Brexpiprazole Aripiprazole may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Brexpiprazole.
Ziprasidone Injection	Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Aripiprazole.
Cariprazine	Cariprazine The risk or severity of adverse effects can be increased when Aripiprazole is combined with Cariprazine.
Eluxadoline	Eluxadoline The risk or severity of constipation can be increased when Aripiprazole is combined with Eluxadoline.
Insulin Degludec (rDNA Origin) Injection	Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Aripiprazole.
Trabectedin Injection	Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Aripiprazole.
Osimertinib	Osimertinib The metabolism of Aripiprazole can be increased when combined with Osimertinib.
Rifapentine	Rifapentine The metabolism of Aripiprazole can be increased when combined with Rifapentine.
Amphotericin B Liposomal Injection	Amphotericin B Liposomal Injection The metabolism of Aripiprazole can be decreased when combined with Amphotericin B.
Dexamethasone Injection	Dexamethasone Injection The metabolism of Aripiprazole can be increased when combined with Dexamethasone.
Brivaracetam Injection	Brivaracetam Injection The risk or severity of adverse effects can be increased when Aripiprazole is combined with Brivaracetam.
Venetoclax	Venetoclax The metabolism of Aripiprazole can be decreased when combined with Venetoclax.
Cobicistat	Cobicistat The metabolism of Aripiprazole can be decreased when combined with Cobicistat.
Midodrine	Midodrine The therapeutic efficacy of Midodrine can be decreased when used in combination with Aripiprazole.
Selexipag	Selexipag The risk or severity of hypotension can be increased when Aripiprazole is combined with Selexipag.
Pimavanserin	Pimavanserin The risk or severity of adverse effects can be increased when Aripiprazole is combined with Pimavanserin.
Diphenhydramine Injection	Diphenhydramine Injection The metabolism of Aripiprazole can be decreased when combined with Diphenhydramine.
Furosemide Injection	Furosemide Injection The risk or severity of hypotension can be increased when Aripiprazole is combined with Furosemide.
Rucaparib	Rucaparib The metabolism of Aripiprazole can be decreased when combined with Rucaparib.
Lixisenatide Injection	Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Aripiprazole.
Ribociclib	Ribociclib The metabolism of Aripiprazole can be decreased when combined with Ribociclib.
Brigatinib	Brigatinib The metabolism of Aripiprazole can be increased when combined with Brigatinib.
Doxepin (Insomnia)	Doxepin (Insomnia) Doxepin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Plecanatide	Plecanatide The therapeutic efficacy of Plecanatide can be decreased when used in combination with Aripiprazole.
Deutetrabenazine	Deutetrabenazine The risk or severity of adverse effects can be increased when Aripiprazole is combined with Deutetrabenazine.
Valbenazine	Valbenazine The metabolism of Valbenazine can be decreased when combined with Aripiprazole.
Deflazacort	Deflazacort The metabolism of Aripiprazole can be increased when combined with Deflazacort.
Safinamide	Safinamide The risk or severity of serotonin syndrome can be increased when Safinamide is combined with Aripiprazole.
Sarilumab Injection	Sarilumab Injection The metabolism of Aripiprazole can be increased when combined with Sarilumab.
Midostaurin	Midostaurin The metabolism of Aripiprazole can be increased when combined with Midostaurin.
Enasidenib	Enasidenib The metabolism of Aripiprazole can be increased when combined with Enasidenib.
Aprepitant/Fosaprepitant Injection	Aprepitant/Fosaprepitant Injection The metabolism of Aripiprazole can be increased when combined with Fosaprepitant.
Copanlisib Injection	Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Aripiprazole.
Delafloxacin	Delafloxacin The metabolism of Aripiprazole can be increased when combined with Delafloxacin.
Acalabrutinib	Acalabrutinib The metabolism of Aripiprazole can be decreased when combined with Acalabrutinib.
Letermovir	Letermovir The metabolism of Aripiprazole can be decreased when combined with Letermovir.
Semaglutide Injection	Semaglutide Injection The therapeutic efficacy of Semaglutide can be decreased when used in combination with Aripiprazole.
Tetrabenazine	Tetrabenazine The risk or severity of adverse effects can be increased when Aripiprazole is combined with Tetrabenazine.
Ertugliflozin	Ertugliflozin The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Aripiprazole.
Buprenorphine Injection	Buprenorphine Injection Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Apalutamide	Apalutamide The metabolism of Aripiprazole can be increased when combined with Apalutamide.
Fostamatinib	Fostamatinib The metabolism of Aripiprazole can be decreased when combined with Fostamatinib.
Lofexidine	Lofexidine The therapeutic efficacy of Aripiprazole can be increased when used in combination with Lofexidine.
Eliglustat	Eliglustat The metabolism of Eliglustat can be decreased when combined with Aripiprazole.
Encorafenib	Encorafenib The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Encorafenib.
Ivosidenib	Ivosidenib The metabolism of Aripiprazole can be increased when combined with Ivosidenib.
Elagolix	Elagolix The metabolism of Elagolix can be decreased when combined with Aripiprazole.
Doravirine	Doravirine The metabolism of Doravirine can be decreased when combined with Aripiprazole.
Tafenoquine	Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Aripiprazole.
Cannabidiol	Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Aripiprazole.
Dacomitinib	Dacomitinib The metabolism of Aripiprazole can be decreased when combined with Dacomitinib.
Stiripentol	Stiripentol The metabolism of Aripiprazole can be decreased when combined with Stiripentol.
Gilteritinib	Gilteritinib The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Gilteritinib.
Glasdegib	Glasdegib The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Glasdegib.
Lorlatinib	Lorlatinib The metabolism of Lorlatinib can be increased when combined with Aripiprazole.
Paclitaxel (with albumin) Injection	Paclitaxel (with albumin) Injection The metabolism of Aripiprazole can be increased when combined with Paclitaxel.
Rifamycin	Rifamycin The metabolism of Aripiprazole can be increased when combined with Rifamycin.
Prucalopride	Prucalopride The therapeutic efficacy of Prucalopride can be decreased when used in combination with Aripiprazole.
Magnesium Citrate	Magnesium Citrate The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Aripiprazole.
Emapalumab-lzsg Injection	Emapalumab-lzsg Injection The metabolism of Aripiprazole can be increased when combined with Emapalumab.
Siponimod	Siponimod The risk or severity of hypertension can be increased when Aripiprazole is combined with Siponimod.
Alpelisib	Alpelisib The metabolism of Aripiprazole can be increased when combined with Alpelisib.
Brexanolone Injection	Brexanolone Injection The risk or severity of adverse effects can be increased when Aripiprazole is combined with Brexanolone.
Solriamfetol	Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Aripiprazole.
Triclabendazole	Triclabendazole The metabolism of Aripiprazole can be decreased when combined with Triclabendazole.
Entrectinib	Entrectinib The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Entrectinib.
Istradefylline	Istradefylline The metabolism of Istradefylline can be decreased when combined with Aripiprazole.
Pitolisant	Pitolisant The therapeutic efficacy of Pitolisant can be decreased when used in combination with Aripiprazole.
Fedratinib	Fedratinib The metabolism of Aripiprazole can be decreased when combined with Fedratinib.
Lefamulin	Lefamulin Lefamulin may increase the QTc-prolonging activities of Aripiprazole.
Phenytoin Injection	Phenytoin Injection The metabolism of Aripiprazole can be increased when combined with Phenytoin.
Fosphenytoin Injection	Fosphenytoin Injection The metabolism of Aripiprazole can be increased when combined with Fosphenytoin.
Lumateperone	Lumateperone The risk or severity of adverse effects can be increased when Aripiprazole is combined with Lumateperone.
Lasmiditan	Lasmiditan The risk or severity of serotonin syndrome can be increased when Aripiprazole is combined with Lasmiditan.
Cenobamate	Cenobamate The serum concentration of Aripiprazole can be decreased when it is combined with Cenobamate.
Selumetinib	Selumetinib The metabolism of Selumetinib can be decreased when combined with Aripiprazole.
Tucatinib	Tucatinib The metabolism of Tucatinib can be decreased when combined with Aripiprazole.
Remdesivir Injection	Remdesivir Injection The metabolism of Aripiprazole can be decreased when combined with Remdesivir.
Selpercatinib	Selpercatinib The risk or severity of hypertension can be increased when Aripiprazole is combined with Selpercatinib.
Lemborexant	Lemborexant Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Lemborexant.
Daratumumab and Hyaluronidase-fihj Injection	Daratumumab and Hyaluronidase-fihj Injection The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Aripiprazole.
Fenfluramine	Fenfluramine The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Aripiprazole.
Fostemsavir	Fostemsavir The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Fostemsavir.
Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection	Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Aripiprazole.
Octreotide	Octreotide The metabolism of Aripiprazole can be decreased when combined with Octreotide.
Pralsetinib	Pralsetinib The metabolism of Aripiprazole can be increased when combined with Pralsetinib.
Opicapone	Opicapone The therapeutic efficacy of Opicapone can be decreased when used in combination with Aripiprazole.
Satralizumab-mwge Injection	Satralizumab-mwge Injection The serum concentration of Aripiprazole can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection	Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Aripiprazole is combined with Naxitamab.
Relugolix	Relugolix The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Relugolix.
Viloxazine	Viloxazine The risk or severity of adverse effects can be increased when Aripiprazole is combined with Viloxazine.
Vitamin E (Alpha-Tocopherol)	Vitamin E (Alpha-Tocopherol) The metabolism of Aripiprazole can be increased when combined with Vitamin E.
Theophylline	Theophylline The metabolism of Aripiprazole can be decreased when combined with Theophylline.
Fenoprofen	Fenoprofen The risk or severity of hypertension can be increased when Fenoprofen is combined with Aripiprazole.
Indomethacin	Indomethacin The risk or severity of hypertension can be increased when Indomethacin is combined with Aripiprazole.
Mefenamic Acid	Mefenamic Acid The risk or severity of hypertension can be increased when Mefenamic acid is combined with Aripiprazole.
Naproxen	Naproxen The risk or severity of hypertension can be increased when Naproxen is combined with Aripiprazole.
Tolmetin	Tolmetin The risk or severity of hypertension can be increased when Tolmetin is combined with Aripiprazole.
Sulindac	Sulindac The risk or severity of hypertension can be increased when Sulindac is combined with Aripiprazole.
Trazodone	Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Aripiprazole.
Hydroxyurea	Hydroxyurea The metabolism of Aripiprazole can be decreased when combined with Hydroxyurea.
Phenobarbital	Phenobarbital The metabolism of Aripiprazole can be increased when combined with Phenobarbital.
Metaxalone	Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Aripiprazole.
Levorphanol	Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Aripiprazole.
Primidone	Primidone The metabolism of Aripiprazole can be increased when combined with Primidone.
Methsuximide	Methsuximide The risk or severity of adverse effects can be increased when Aripiprazole is combined with Methsuximide.
Diethylpropion	Diethylpropion Diethylpropion may decrease the sedative and stimulatory activities of Aripiprazole.
Chlorpromazine	Chlorpromazine Chlorpromazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Diazepam	Diazepam The metabolism of Aripiprazole can be decreased when combined with Diazepam.
Oxazepam	Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Aripiprazole.
Flurazepam	Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Aripiprazole.
Clorazepate	Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Aripiprazole.
Lorazepam	Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Aripiprazole.
Phenoxybenzamine	Phenoxybenzamine Aripiprazole may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phenoxybenzamine.
Amantadine	Amantadine The therapeutic efficacy of Amantadine can be decreased when used in combination with Aripiprazole.
Codeine	Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Aripiprazole.
Meprobamate	Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Aripiprazole.
Chlordiazepoxide	Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Aripiprazole.
Bromocriptine	Bromocriptine Bromocriptine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Metaproterenol	Metaproterenol The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Aripiprazole.
Tranylcypromine	Tranylcypromine The metabolism of Aripiprazole can be decreased when combined with Tranylcypromine.
Phenelzine	Phenelzine The metabolism of Aripiprazole can be decreased when combined with Phenelzine.
Procarbazine	Procarbazine The risk or severity of serotonin syndrome can be increased when Procarbazine is combined with Aripiprazole.
Ergoloid Mesylates	Ergoloid Mesylates The risk or severity of adverse effects can be decreased when Ergoloid mesylate is combined with Aripiprazole.
Tetracycline	Tetracycline The metabolism of Aripiprazole can be decreased when combined with Tetracycline.
Minocycline	Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.
Prochlorperazine	Prochlorperazine The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Aripiprazole.
Thioridazine	Thioridazine Thioridazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Trifluoperazine	Trifluoperazine Trifluoperazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Dapsone	Dapsone The metabolism of Aripiprazole can be decreased when combined with Dapsone.
Sulfadiazine	Sulfadiazine The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Aripiprazole.
Oxycodone	Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Aripiprazole.
Methadone	Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Aripiprazole.
Oxybutynin	Oxybutynin The metabolism of Aripiprazole can be decreased when combined with Oxybutynin.
Benztropine	Benztropine The risk or severity of adverse effects can be increased when Aripiprazole is combined with Benzatropine.
Maprotiline	Maprotiline The risk or severity of adverse effects can be increased when Maprotiline is combined with Aripiprazole.
Ibuprofen	Ibuprofen The risk or severity of hypertension can be increased when Ibuprofen is combined with Aripiprazole.
Trihexyphenidyl	Trihexyphenidyl The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Aripiprazole.
Orphenadrine	Orphenadrine Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.
Perphenazine	Perphenazine The risk or severity of adverse effects can be increased when Perphenazine is combined with Aripiprazole.
Fluphenazine	Fluphenazine The risk or severity of adverse effects can be increased when Fluphenazine is combined with Aripiprazole.
Phentermine	Phentermine Phentermine may decrease the sedative and stimulatory activities of Aripiprazole.
Methylphenidate	Methylphenidate The risk or severity of adverse effects can be increased when Aripiprazole is combined with Methylphenidate.
Amoxapine	Amoxapine Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Sulfasalazine	Sulfasalazine The risk or severity of hypertension can be increased when Sulfasalazine is combined with Aripiprazole.
Hydrocortisone	Hydrocortisone The metabolism of Aripiprazole can be increased when combined with Hydrocortisone.
Doxorubicin	Doxorubicin The metabolism of Aripiprazole can be decreased when combined with Doxorubicin.
Mechlorethamine	Mechlorethamine The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Mechlorethamine.
Pyridostigmine	Pyridostigmine The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Pyridostigmine.
Carbamazepine	Carbamazepine The metabolism of Aripiprazole can be increased when combined with Carbamazepine.
Molindone	Molindone The risk or severity of adverse effects can be increased when Aripiprazole is combined with Molindone.
Methyldopa	Methyldopa The risk or severity of hypotension can be increased when Aripiprazole is combined with Methyldopa.
Clonidine	Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Aripiprazole.
Prazosin	Prazosin Aripiprazole may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Prazosin.
Hydralazine	Hydralazine The metabolism of Aripiprazole can be decreased when combined with Hydralazine.
Cimetidine	Cimetidine The metabolism of Aripiprazole can be decreased when combined with Cimetidine.
Warfarin	Warfarin The metabolism of Warfarin can be increased when combined with Aripiprazole.
Clonazepam	Clonazepam The risk or severity of adverse effects can be increased when Clonazepam is combined with Aripiprazole.
Loperamide	Loperamide The metabolism of Aripiprazole can be decreased when combined with Loperamide.
Promethazine	Promethazine The metabolism of Aripiprazole can be decreased when combined with Promethazine.
Meclofenamate	Meclofenamate The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Aripiprazole.
Daunorubicin	Daunorubicin The metabolism of Aripiprazole can be decreased when combined with Daunorubicin.
Griseofulvin	Griseofulvin The metabolism of Aripiprazole can be increased when combined with Griseofulvin.
Digoxin	Digoxin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Aripiprazole.
Loxapine	Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Aripiprazole.
Chloroquine	Chloroquine The metabolism of Aripiprazole can be decreased when combined with Chloroquine.
Quinine	Quinine The metabolism of Aripiprazole can be increased when combined with Quinine.
Ethosuximide	Ethosuximide Ethosuximide may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.
Calcitriol	Calcitriol The metabolism of Aripiprazole can be increased when combined with Calcitriol.
Triamterene	Triamterene Aripiprazole may increase the hypotensive activities of Triamterene.
Lactulose	Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Aripiprazole.
Sulfinpyrazone	Sulfinpyrazone The metabolism of Aripiprazole can be increased when combined with Sulfinpyrazone.
Chlorothiazide	Chlorothiazide The risk or severity of hypotension can be increased when Aripiprazole is combined with Chlorothiazide.
Chlorthalidone	Chlorthalidone The risk or severity of hypotension can be increased when Aripiprazole is combined with Chlorthalidone.
Metolazone	Metolazone The risk or severity of hypotension can be increased when Aripiprazole is combined with Metolazone.
Clindamycin Injection	Clindamycin Injection The metabolism of Aripiprazole can be decreased when combined with Clindamycin.
Secobarbital	Secobarbital The metabolism of Aripiprazole can be increased when combined with Secobarbital.
Desipramine	Desipramine The metabolism of Aripiprazole can be decreased when combined with Desipramine.
Amitriptyline	Amitriptyline Amitriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Imipramine	Imipramine Imipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Probenecid	Probenecid The metabolism of Aripiprazole can be increased when combined with Probenecid.
Quinidine	Quinidine Quinidine may decrease the excretion rate of Aripiprazole which could result in a higher serum level.
Procainamide	Procainamide The metabolism of Procainamide can be decreased when combined with Aripiprazole.
Isoniazid	Isoniazid The metabolism of Aripiprazole can be decreased when combined with Isoniazid.
Rifampin	Rifampin The metabolism of Aripiprazole can be increased when combined with Rifampicin.
Disopyramide	Disopyramide The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Disopyramide.
Valproic Acid	Valproic Acid The metabolism of Aripiprazole can be decreased when combined with Valproic acid.
Tamoxifen	Tamoxifen The metabolism of Aripiprazole can be increased when combined with Tamoxifen.
Butabarbital	Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Aripiprazole.
Methimazole	Methimazole The metabolism of Aripiprazole can be decreased when combined with Methimazole.
Chlorpropamide	Chlorpropamide The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Aripiprazole.
Glucagon Injection	Glucagon Injection Aripiprazole may increase the gastrointestinal motility reducing activities of Glucagon.
Tolbutamide	Tolbutamide The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Aripiprazole.
Tolazamide	Tolazamide The therapeutic efficacy of Tolazamide can be decreased when used in combination with Aripiprazole.
Dextromethorphan	Dextromethorphan The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Aripiprazole.
Cyclobenzaprine	Cyclobenzaprine The risk or severity of CNS depression can be increased when Aripiprazole is combined with Cyclobenzaprine.
Niacin	Niacin The metabolism of Aripiprazole can be decreased when combined with Niacin.
Baclofen	Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Aripiprazole.
Doxylamine	Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.
Cyproheptadine	Cyproheptadine Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.
Clemastine	Clemastine The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Clemastine.
Chlorpheniramine	Chlorpheniramine The metabolism of Aripiprazole can be decreased when combined with Chlorpheniramine.
Brompheniramine	Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Aripiprazole.
Meclizine	Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Aripiprazole.
Methyclothiazide	Methyclothiazide Aripiprazole may increase the hypotensive activities of Methyclothiazide.
Hydrochlorothiazide	Hydrochlorothiazide The risk or severity of hypotension can be increased when Aripiprazole is combined with Hydrochlorothiazide.
Dantrolene	Dantrolene The risk or severity of adverse effects can be increased when Dantrolene is combined with Aripiprazole.
Chlorzoxazone	Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Aripiprazole.
Carisoprodol	Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Aripiprazole.
Methocarbamol	Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Aripiprazole.
Danazol	Danazol The metabolism of Aripiprazole can be decreased when combined with Danazol.
Disulfiram	Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Aripiprazole.
Propranolol (Cardiovascular)	Propranolol (Cardiovascular) The risk or severity of hypotension can be increased when Aripiprazole is combined with Propranolol.
Minoxidil	Minoxidil The risk or severity of hypotension can be increased when Aripiprazole is combined with Minoxidil.
Pseudoephedrine	Pseudoephedrine Pseudoephedrine may decrease the sedative and stimulatory activities of Aripiprazole.
Nortriptyline	Nortriptyline Nortriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Spironolactone	Spironolactone Aripiprazole may increase the hypotensive activities of Spironolactone.
Amphotericin B Injection	Amphotericin B Injection The metabolism of Aripiprazole can be decreased when combined with Amphotericin B.
Nadolol	Nadolol The risk or severity of hypotension can be increased when Aripiprazole is combined with Nadolol.
Butorphanol Injection	Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Aripiprazole.
Nalbuphine Injection	Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Aripiprazole.
Oxytocin Injection	Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Aripiprazole.
Trimethobenzamide	Trimethobenzamide Trimethobenzamide may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.
Flavoxate	Flavoxate Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Papaverine	Papaverine The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Papaverine.
Fluorouracil Injection	Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Fluorouracil.
Colchicine	Colchicine The metabolism of Aripiprazole can be increased when combined with Colchicine.
Acetazolamide	Acetazolamide The metabolism of Aripiprazole can be decreased when combined with Acetazolamide.
Ketoconazole	Ketoconazole The metabolism of Aripiprazole can be decreased when combined with Ketoconazole.
Pyrantel	Pyrantel The risk or severity of adverse effects can be increased when Aripiprazole is combined with Pyrantel.
Thiotepa Injection	Thiotepa Injection The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Thiotepa.
Vincristine Injection	Vincristine Injection The metabolism of Aripiprazole can be decreased when combined with Vincristine.
Captopril	Captopril The risk or severity of hypotension can be increased when Aripiprazole is combined with Captopril.
Dipyridamole	Dipyridamole The risk or severity of hypotension, dyspepsia, and headache can be increased when Dipyridamole is combined with Aripiprazole.
Isoxsuprine	Isoxsuprine The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Aripiprazole.
Vinblastine	Vinblastine The metabolism of Aripiprazole can be increased when combined with Vinblastine.
Ethacrynic Acid	Ethacrynic Acid Aripiprazole may increase the hypotensive activities of Etacrynic acid.
Metoprolol	Metoprolol The metabolism of Metoprolol can be decreased when combined with Aripiprazole.
Hydroxyzine	Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Aripiprazole.
Thiothixene	Thiothixene The risk or severity of adverse effects can be increased when Aripiprazole is combined with Thiothixene.
Aspirin	Aspirin The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Aripiprazole.
Salsalate	Salsalate The risk or severity of hypertension can be increased when Aripiprazole is combined with Salsalate.
Alprazolam	Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Aripiprazole.
Temazepam	Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Aripiprazole.
Triazolam	Triazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Aripiprazole.
Dicyclomine	Dicyclomine Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine	Hyoscyamine Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline	Propantheline Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Diltiazem	Diltiazem The metabolism of Aripiprazole can be decreased when combined with Diltiazem.
Nifedipine	Nifedipine The metabolism of Aripiprazole can be increased when combined with Nifedipine.
Timolol	Timolol The risk or severity of hypotension can be increased when Aripiprazole is combined with Timolol.
Verapamil	Verapamil Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Atenolol	Atenolol The risk or severity of hypotension can be increased when Aripiprazole is combined with Atenolol.
Pindolol	Pindolol The risk or severity of hypotension can be increased when Aripiprazole is combined with Pindolol.
Cisplatin Injection	Cisplatin Injection The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Cisplatin.
Diflunisal	Diflunisal The risk or severity of hypertension can be increased when Diflunisal is combined with Aripiprazole.
Piroxicam	Piroxicam The risk or severity of hypertension can be increased when Piroxicam is combined with Aripiprazole.
Bumetanide	Bumetanide Aripiprazole may increase the hypotensive activities of Bumetanide.
Etoposide	Etoposide The metabolism of Aripiprazole can be increased when combined with Etoposide.
Glyburide	Glyburide The metabolism of Aripiprazole can be decreased when combined with Glyburide.
Glipizide	Glipizide The therapeutic efficacy of Glipizide can be decreased when used in combination with Aripiprazole.
Indapamide	Indapamide The risk or severity of hypotension can be increased when Aripiprazole is combined with Indapamide.
Dicloxacillin	Dicloxacillin The metabolism of Aripiprazole can be increased when combined with Dicloxacillin.
Nafcillin Injection	Nafcillin Injection The metabolism of Aripiprazole can be increased when combined with Nafcillin.
Pentoxifylline	Pentoxifylline The risk or severity of hypotension, dyspepsia, and headache can be increased when Pentoxifylline is combined with Aripiprazole.
Pentamidine Injection	Pentamidine Injection The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Pentamidine.
Labetalol	Labetalol Aripiprazole may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Labetalol.
Leuprolide Injection	Leuprolide Injection The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Leuprolide.
Guanabenz	Guanabenz The risk or severity of hypotension can be increased when Aripiprazole is combined with Guanabenz.
Ketoprofen	Ketoprofen The risk or severity of hypertension can be increased when Ketoprofen is combined with Aripiprazole.
Pimozide	Pimozide The metabolism of Aripiprazole can be decreased when combined with Pimozide.
Enalapril	Enalapril The risk or severity of hypotension can be increased when Aripiprazole is combined with Enalapril.
Flurbiprofen	Flurbiprofen The risk or severity of hypertension can be increased when Flurbiprofen is combined with Aripiprazole.
Amiodarone	Amiodarone The metabolism of Aripiprazole can be decreased when combined with Amiodarone.
Buspirone	Buspirone The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Aripiprazole.
Lovastatin	Lovastatin The metabolism of Aripiprazole can be decreased when combined with Lovastatin.
Ciprofloxacin	Ciprofloxacin The metabolism of Aripiprazole can be decreased when combined with Ciprofloxacin.
Mesalamine	Mesalamine The risk or severity of hypertension can be increased when Mesalazine is combined with Aripiprazole.
Diclofenac	Diclofenac The risk or severity of hypertension can be increased when Diclofenac is combined with Aripiprazole.
Fluoxetine	Fluoxetine The serum concentration of Fluoxetine can be increased when it is combined with Aripiprazole.
Nimodipine	Nimodipine The risk or severity of hypotension can be increased when Aripiprazole is combined with Nimodipine.
Clozapine	Clozapine Clozapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Estazolam	Estazolam The risk or severity of adverse effects can be increased when Estazolam is combined with Aripiprazole.
Idarubicin	Idarubicin The metabolism of Aripiprazole can be decreased when combined with Idarubicin.
Ofloxacin	Ofloxacin The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Ofloxacin.
Didanosine	Didanosine Didanosine may increase the neurotoxic activities of Aripiprazole.
Clarithromycin	Clarithromycin The metabolism of Aripiprazole can be decreased when combined with Clarithromycin.
Benazepril	Benazepril The risk or severity of hypotension can be increased when Aripiprazole is combined with Benazepril.
Etodolac	Etodolac The risk or severity of hypertension can be increased when Etodolac is combined with Aripiprazole.
Felodipine	Felodipine The metabolism of Aripiprazole can be decreased when combined with Felodipine.
Fosinopril	Fosinopril The risk or severity of hypotension can be increased when Aripiprazole is combined with Fosinopril.
Nabumetone	Nabumetone The risk or severity of hypertension can be increased when Nabumetone is combined with Aripiprazole.
Quinapril	Quinapril The risk or severity of hypotension can be increased when Aripiprazole is combined with Quinapril.
Ramipril	Ramipril The risk or severity of hypotension can be increased when Aripiprazole is combined with Ramipril.
Simvastatin	Simvastatin The metabolism of Aripiprazole can be decreased when combined with Simvastatin.
Amlodipine	Amlodipine The risk or severity of hypotension can be increased when Aripiprazole is combined with Amlodipine.
Teniposide Injection	Teniposide Injection The metabolism of Aripiprazole can be decreased when combined with Teniposide.
Itraconazole	Itraconazole The metabolism of Aripiprazole can be decreased when combined with Itraconazole.
Lisinopril	Lisinopril The risk or severity of hypotension can be increased when Aripiprazole is combined with Lisinopril.
Oxaprozin	Oxaprozin The risk or severity of hypertension can be increased when Oxaprozin is combined with Aripiprazole.
Rifabutin	Rifabutin The metabolism of Aripiprazole can be increased when combined with Rifabutin.
Sotalol	Sotalol The metabolism of Sotalol can be decreased when combined with Aripiprazole.
Bisoprolol	Bisoprolol The risk or severity of hypotension can be increased when Aripiprazole is combined with Bisoprolol.
Zolpidem	Zolpidem Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin	Doxazosin Aripiprazole may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxazosin.
Terazosin	Terazosin Aripiprazole may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Terazosin.
Isradipine	Isradipine The metabolism of Aripiprazole can be decreased when combined with Isradipine.
Omeprazole	Omeprazole The metabolism of Aripiprazole can be increased when combined with Omeprazole.
Cisapride	Cisapride The metabolism of Cisapride can be decreased when combined with Aripiprazole.
Gabapentin	Gabapentin The risk or severity of adverse effects can be increased when Gabapentin is combined with Aripiprazole.
Fluvastatin	Fluvastatin The metabolism of Aripiprazole can be decreased when combined with Fluvastatin.
Venlafaxine	Venlafaxine The metabolism of Aripiprazole can be decreased when combined with Venlafaxine.
Nizatidine	Nizatidine The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Nizatidine.
Stavudine	Stavudine Stavudine may increase the neurotoxic activities of Aripiprazole.
Fluvoxamine	Fluvoxamine The metabolism of Aripiprazole can be decreased when combined with Fluvoxamine.
Nefazodone	Nefazodone Nefazodone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Lamotrigine	Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Aripiprazole.
Losartan	Losartan The metabolism of Aripiprazole can be decreased when combined with Losartan.
Tramadol	Tramadol The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Aripiprazole.
Vinorelbine Injection	Vinorelbine Injection The metabolism of Aripiprazole can be decreased when combined with Vinorelbine.
Moexipril	Moexipril The risk or severity of hypotension can be increased when Aripiprazole is combined with Moexipril.
Lansoprazole	Lansoprazole The metabolism of Aripiprazole can be increased when combined with Lansoprazole.
Ifosfamide Injection	Ifosfamide Injection The metabolism of Aripiprazole can be increased when combined with Ifosfamide.
Nicardipine	Nicardipine Nicardipine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Bupropion	Bupropion The metabolism of Aripiprazole can be decreased when combined with Bupropion.
Ticlopidine	Ticlopidine The metabolism of Aripiprazole can be decreased when combined with Ticlopidine.
Saquinavir	Saquinavir The metabolism of Aripiprazole can be decreased when combined with Saquinavir.
Metformin	Metformin The therapeutic efficacy of Metformin can be decreased when used in combination with Aripiprazole.
Nisoldipine	Nisoldipine The risk or severity of hypotension can be increased when Aripiprazole is combined with Nisoldipine.
Riluzole	Riluzole The risk or severity of adverse effects can be increased when Riluzole is combined with Aripiprazole.
Amifostine Injection	Amifostine Injection Aripiprazole may increase the hypotensive activities of Amifostine.
Acarbose	Acarbose The therapeutic efficacy of Acarbose can be decreased when used in combination with Aripiprazole.
Glimepiride	Glimepiride The therapeutic efficacy of Glimepiride can be decreased when used in combination with Aripiprazole.
Indinavir	Indinavir The metabolism of Aripiprazole can be decreased when combined with Indinavir.
Ritonavir	Ritonavir The metabolism of Aripiprazole can be decreased when combined with Ritonavir.
Docetaxel Injection	Docetaxel Injection The metabolism of Aripiprazole can be decreased when combined with Docetaxel.
Clomipramine	Clomipramine The metabolism of Aripiprazole can be decreased when combined with Clomipramine.
Zafirlukast	Zafirlukast The metabolism of Aripiprazole can be decreased when combined with Zafirlukast.
Mirtazapine	Mirtazapine Aripiprazole may increase the serotonergic activities of Mirtazapine.
Trandolapril	Trandolapril The risk or severity of hypotension can be increased when Aripiprazole is combined with Trandolapril.
Topiramate	Topiramate The risk or severity of hyperthermia and oligohydrosis can be increased when Aripiprazole is combined with Topiramate.
Valsartan	Valsartan The risk or severity of hypotension can be increased when Aripiprazole is combined with Valsartan.
Insulin Lispro Injection	Insulin Lispro Injection The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Aripiprazole.
Pramipexole	Pramipexole The therapeutic efficacy of Pramipexole can be decreased when used in combination with Aripiprazole.
Donepezil	Donepezil The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Donepezil.
Nelfinavir	Nelfinavir The metabolism of Aripiprazole can be decreased when combined with Nelfinavir.
Azithromycin	Azithromycin The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Azithromycin.
Loratadine	Loratadine Aripiprazole may increase the anticholinergic activities of Loratadine.
Carvedilol	Carvedilol Aripiprazole may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.
Flutamide	Flutamide The metabolism of Aripiprazole can be decreased when combined with Flutamide.
Selegiline	Selegiline The risk or severity of serotonin syndrome can be increased when Selegiline is combined with Aripiprazole.
Bicalutamide	Bicalutamide The metabolism of Aripiprazole can be decreased when combined with Bicalutamide.
Sertraline	Sertraline The serum concentration of Aripiprazole can be increased when it is combined with Sertraline.
Propafenone	Propafenone The metabolism of Aripiprazole can be decreased when combined with Propafenone.
Raloxifene	Raloxifene The metabolism of Aripiprazole can be decreased when combined with Raloxifene.
Irbesartan	Irbesartan The metabolism of Aripiprazole can be decreased when combined with Irbesartan.
Tamsulosin	Tamsulosin Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Ropinirole	Ropinirole The therapeutic efficacy of Ropinirole can be decreased when used in combination with Aripiprazole.
Finasteride	Finasteride The metabolism of Aripiprazole can be decreased when combined with Finasteride.
Quetiapine	Quetiapine Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Cetirizine	Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Aripiprazole.
Paroxetine	Paroxetine The metabolism of Aripiprazole can be decreased when combined with Paroxetine.
Tolcapone	Tolcapone The therapeutic efficacy of Tolcapone can be decreased when used in combination with Aripiprazole.
Citalopram	Citalopram The metabolism of Aripiprazole can be decreased when combined with Citalopram.
Efavirenz	Efavirenz The metabolism of Aripiprazole can be increased when combined with Efavirenz.
Sildenafil	Sildenafil The risk or severity of hypotension, dyspepsia, and headache can be increased when Sildenafil is combined with Aripiprazole.
Pioglitazone	Pioglitazone The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Aripiprazole.
Celecoxib	Celecoxib The metabolism of Aripiprazole can be decreased when combined with Celecoxib.
Rosiglitazone	Rosiglitazone The metabolism of Aripiprazole can be decreased when combined with Rosiglitazone.
Tolterodine	Tolterodine Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.
Thalidomide	Thalidomide Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Balsalazide	Balsalazide The risk or severity of hypertension can be increased when Balsalazide is combined with Aripiprazole.
Nateglinide	Nateglinide The therapeutic efficacy of Nateglinide can be decreased when used in combination with Aripiprazole.
Galantamine	Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Aripiprazole.
Levetiracetam	Levetiracetam The risk or severity of adverse effects can be increased when Levetiracetam is combined with Aripiprazole.
Rabeprazole	Rabeprazole The metabolism of Aripiprazole can be decreased when combined with Rabeprazole.
Terbinafine	Terbinafine The metabolism of Aripiprazole can be increased when combined with Terbinafine.